Skip to main content
logo
XBiotech Inc. (XBIT)
NASDAQ: XBIT · Real-Time Price · USD
1.840
-0.090 (-4.66%)
Oct 26, 2026, 1:19 PM EDT - Market open

XBiotech Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
----4.0118.39
Revenue Growth
-----78.20%-58.19%
Gross Profit
----3.3612.57
Operating Income
-48.22-55.69-42.47-37.51-34.49-25.08
Net Income
-45.13-45.54-38.53-24.56-32.9-17.41
Earnings Per Share
-1.48-1.49-1.26-0.81-1.08-0.58
EPS Growth
------

Cash & Debt
Chart
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
109.53125.55172.68200.02217.48236.98
Total Debt
--10.25---
Net Cash (Debt)
109.53125.55162.43200.02217.48236.98
Net Cash Growth
-28.38%-22.70%-18.80%-8.03%-8.23%-0.16%
Net Cash Per Share
3.594.125.336.577.147.89

Cash Flow & CapEx
Chart
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-40.7-39.92-30.96-18.73-14.8269.45
Capital Expenditures
-0.14-0.29-1.3-0.36-0.59-3.53
Free Cash Flow
-40.84-40.21-32.27-19.09-15.4165.92
Free Cash Flow Growth
------

Margins
Chart
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
----83.77%68.36%
Operating Margin
-----860.10%-136.36%
Pretax Margin
-----837.61%-138.40%
Profit Margin
-----820.45%-94.67%
FCF Margin
-----384.26%358.38%

Valuation
Chart
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingOct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Forward PE
-87.6387.6387.6387.6387.63
P/FCF Ratio
-----5.13
PS Ratio
----26.6418.39